That's a helpful quote...although still, I get the
Post# of 157599

Since NP got CYDY so ahead of its skis before, and so many investors were trying to communicate with the FDA, I still feel it would have been better to write the company and make sure they're aware of the opportunity so *they*could write with more capital, iykwim,, rather than lump LL in with the perfume and horse dewormer and god knows what else submissions...we need to err on the side of formal procedure, IMO.

